UCB (EBR:UCB) said today that its Cimzia AutoClicks pre-filled pen is available in the U.K., after the European Medicines Agency’s Committee for Medicinal Products for Human Use recommended the device for all approved indications, including rheumatoid arthritis and axial spondyloarthritis. The Belgian company partnered with OXO to develop the pen, based on technology licensed from Bespak. The […]
MASSDEVICE ON CALL — Uncertainty surrounding the use of cardiac stents and angioplasty balloons may lead to a market backlash against the devices and their makers.
At least 4 percent and up to 12 percent of percutaneous coronary interventions may be implanted outside of industry-recommended guidelines, according to an article published in the Journal of the American Medical Assn. yesterday.